about
Management of refractory status epilepticus in adults: still more questions than answersStandardized EEG interpretation accurately predicts prognosis after cardiac arrestCSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosisRobust discrimination between EEG responses to categories of environmental sounds in early coma.Ictal asystole with convulsive syncope mimicking secondary generalisation: a depth electrode studyYield of intermittent versus continuous EEG in comatose survivors of cardiac arrest treated with hypothermiaPredicting neurological outcome after cardiac arrest.Magnetoencephalography demonstrates multiple asynchronous generators during human sleep spindles.A randomized trial for the treatment of refractory status epilepticus.Vagus nerve stimulator treatment in adult-onset Rasmussen's encephalitis.Effect of vagus nerve stimulation in an adult patient with Dravet syndrome: contribution to sudden unexpected death in epilepsy risk reduction?.Pulse wave amplitude drops during sleep are reliable surrogate markers of changes in cortical activity.Propofol treatment of refractory status epilepticus: a study of 31 episodes.Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine.Recurrent Wernicke's aphasia: migraine and not stroke!The human K-complex represents an isolated cortical down-state.[Multimodal neuromonitoring for the critical care management of acute coma].Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.Status epilepticus of inflammatory etiology: a cohort studyProperties of functional brain networks correlate with frequency of psychogenic non-epileptic seizures.Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.Evaluation of a clinical tool for early etiology identification in status epilepticus.Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison.Which anesthetic should be used in the treatment of refractory status epilepticus?Prevalence and Mimics of Kleine-Levin Syndrome: A Survey in French-Speaking Switzerland.Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A New Challenging Entity for Consultation-Liaison PsychiatristSeizure semiology: an overview of the 'inverse problem'.Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.Epilepsy in brain tumor patients.What is the value of hypothermia in acute neurologic diseases and status epilepticus?Proposition: limbic encephalitis may represent limbic status epilepticus. A review of clinical and EEG characteristics.Advances in the hospital management of patients following an out of hospital cardiac arrest.Transarterial embolization in acute colonic bleeding: review of 11 years of experience and long-term results.Serum procalcitonin as a marker of post-cardiac arrest syndrome and long-term neurological recovery, but not of early-onset infections, in comatose post-anoxic patients treated with therapeutic hypothermia.[Neurology].Contemporary approach to neurologic prognostication of coma after cardiac arrest.A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus.Should Postanoxic Status Epilepticus be Treated Aggressively?-No!EEG as an Indicator of Cerebral Functioning in Postanoxic Coma.Clinical Use of EEG in the ICU: Technical Setting.
P50
Q27028089-92A287F3-5F8D-454C-8AA2-D1926627B076Q27348532-F0507AF4-34BC-42EF-A62E-6A138F53114CQ28280548-B2555248-B5B9-41AE-B9D0-413296009741Q30441965-F646FE95-2A72-46FC-B7A3-F8AD67FA0175Q33152698-9C5915C5-BE25-40F2-9E74-40731E29E238Q33750386-272821DE-0847-4AFE-841D-1F9D7ACE1B5EQ33827879-BEB71BCC-E03E-4085-828F-4BF0901E30C3Q33995315-D4C3D820-D922-4094-BD79-072B543820BFQ34024128-D2522FC1-9553-4AD6-9BB3-F55F50ABE4B0Q34153289-6D7AD7DE-880F-4B43-9510-DC93DA8DE2E1Q34315236-0D186B7D-2290-4C61-A554-5930710B3068Q34315465-1F4EA734-2452-4D11-9713-59D21D32CDD3Q34330637-DDF4B958-CF27-4466-B7B8-A4C25E3597D7Q34553537-71C7104F-7143-4F60-A8F5-5741952849B5Q34982041-F6BEFBFD-CBF5-4007-A4AC-6BAD826F4DABQ34982450-027DA282-4C23-4500-B4A8-0BF7100C74B4Q35551203-003F2F26-4D42-4F7A-AC9C-C2AF0C175BBBQ35691532-3E181EEC-8437-4EEC-BD11-E081AE7F84CFQ35945746-42722748-C7EB-46E1-850E-A2B813441310Q36479364-A5683CE4-0E69-4E10-8AEC-E6493EC2F682Q36620651-0C8EC292-54C4-4F84-81F4-687A8C887217Q36909082-94855E8A-9872-497D-9371-85555C301AC6Q36927224-BDF06AF8-DF4E-495E-AE87-A16C19B26281Q37106001-AA781992-B5BD-4959-9714-FE38C44D3DC5Q37117675-8E21325F-C5CE-4D9A-B937-EFE5E437717EQ37123615-8C3A0251-0252-4057-89A1-98CFF329A59DQ37634864-CA829ABD-6A10-4F65-A303-21EB277067EAQ37641223-784B0704-8663-468B-933A-EFFA1BCC6E53Q37781984-F7D0702A-5DEB-4D4C-B2CC-2A2C9E2EC5A6Q37941818-F2B93F2C-96D5-4D3E-9D5A-84912E1FD79BQ37998281-BC591637-B9E7-4953-922A-45DA9438D525Q38014803-480A785C-B5B1-429F-9CCE-C2764DD6DED6Q38064757-ABB77F34-F097-4CD5-986E-3A6092E1CA6DQ38079049-D812DC04-37DF-438A-828B-3E84A0B8A83AQ38157895-6B30788C-0E92-4B15-B50F-BD93FAE5D3C7Q38264811-304B141D-96BB-42EA-A63B-DC5C86DB730CQ38580125-8E2DEFA3-296F-4887-8379-0A9844581B1DQ38656606-1109E920-222D-4F8B-B04B-9BC6C0295831Q38656618-94932484-0B87-4850-940D-CCAFD53BCCB9Q38656627-491807F5-85A4-415A-BF83-93E2F72FD759
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrea O Rossetti
@ast
Andrea O Rossetti
@en
Andrea O Rossetti
@es
Andrea O Rossetti
@nl
type
label
Andrea O Rossetti
@ast
Andrea O Rossetti
@en
Andrea O Rossetti
@es
Andrea O Rossetti
@nl
altLabel
A O Rossetti
@en
A-O Rossetti
@en
Andrea Rossetti
@en
Rossetti AO
@en
prefLabel
Andrea O Rossetti
@ast
Andrea O Rossetti
@en
Andrea O Rossetti
@es
Andrea O Rossetti
@nl
P1053
A-6712-2008
P106
P31
P3829
P496
0000-0002-7878-172X
P569
2000-01-01T00:00:00Z